{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:18:25Z","timestamp":1769923105506,"version":"3.49.0"},"reference-count":26,"publisher":"Baishideng Publishing Group Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4254\/wjh.v5.i12.685","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T03:51:56Z","timestamp":1394164316000},"page":"685","source":"Crossref","is-referenced-by-count":31,"title":["Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study"],"prefix":"10.4254","volume":"5","author":[{"given":"Anna","family":"Licata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.06.024"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, Navasa M, Clària J, Rimola A, Arroyo V. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-236.","DOI":"10.1016\/0016-5085(93)90031-7"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:1106-1115.","DOI":"10.1056\/NEJM199604253341707"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003;38 Suppl 1:S69-S89.","DOI":"10.1016\/S0168-8278(03)00007-2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080532"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20766"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.02.001"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040323"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164-176.","DOI":"10.1002\/hep.510230122"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.561200"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.107789"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.03.012"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.043"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.014"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.024"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0809139"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Neri S, Pulvirenti D, Malaguarnera M, Cosimo BM, Bertino G, Ignaccolo L, Siringo S, Castellino P. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig Dis Sci 2008;53:830-835.","DOI":"10.1007\/s10620-007-9919-9"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 2003;18:152-156.","DOI":"10.1046\/j.1440-1746.2003.02934.x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23286"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005162.pub3"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, Salinas F, Donà S, Fagiuoli S, Sticca A. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007;45:223-229.","DOI":"10.1002\/hep.21443"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, Duhamel C, Lebrec D, Poynard T, Moreau R. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007;46:1872-1882.","DOI":"10.1002\/hep.21920"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J, Ginès P. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005;41:1282-1289.","DOI":"10.1002\/hep.20687"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.193227"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.06.014"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T02:24:04Z","timestamp":1565231044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v5\/i12\/685.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v5.i12.685","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}